These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19903338)

  • 1. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study.
    Thompson DJ; Leach MO; Kwan-Lim G; Gayther SA; Ramus SJ; Warsi I; Lennard F; Khazen M; Bryant E; Reed S; Boggis CR; Evans DG; Eeles RA; Easton DF; Warren RM;
    Breast Cancer Res; 2009; 11(6):R80. PubMed ID: 19903338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of mammographic density among women with a strong family history of breast cancer.
    Moran O; Eisen A; Demsky R; Blackmore K; Knight JA; Panchal S; Ginsburg O; Zbuk K; Yaffe M; Metcalfe KA; Narod SA; Kotsopoulos J
    BMC Cancer; 2019 Jun; 19(1):631. PubMed ID: 31242899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
    Leach MO; Boggis CR; Dixon AK; Easton DF; Eeles RA; Evans DG; Gilbert FJ; Griebsch I; Hoff RJ; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Thompson D; Warren RM;
    Lancet; 2005 May 21-27; 365(9473):1769-78. PubMed ID: 15910949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging.
    Khazen M; Warren RM; Boggis CR; Bryant EC; Reed S; Warsi I; Pointon LJ; Kwan-Lim GE; Thompson D; Eeles R; Easton D; Evans DG; Leach MO;
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2268-74. PubMed ID: 18768492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Mitchell G; Antoniou AC; Warren R; Peock S; Brown J; Davies R; Mattison J; Cook M; Warsi I; Evans DG; Eccles D; Douglas F; Paterson J; Hodgson S; Izatt L; Cole T; Burgess L; Eeles R; Easton DF
    Cancer Res; 2006 Feb; 66(3):1866-72. PubMed ID: 16452249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumetric mammographic density: heritability and association with breast cancer susceptibility loci.
    Brand JS; Humphreys K; Thompson DJ; Li J; Eriksson M; Hall P; Czene K
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.
    Plevritis SK; Kurian AW; Sigal BM; Daniel BL; Ikeda DM; Stockdale FE; Garber AM
    JAMA; 2006 May; 295(20):2374-84. PubMed ID: 16720823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study.
    Gierach GL; Li H; Loud JT; Greene MH; Chow CK; Lan L; Prindiville SA; Eng-Wong J; Soballe PW; Giambartolomei C; Mai PL; Galbo CE; Nichols K; Calzone KA; Olopade OI; Gail MH; Giger ML
    Breast Cancer Res; 2014; 16(4):424. PubMed ID: 25159706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common genetic variation and novel loci associated with volumetric mammographic density.
    Brand JS; Humphreys K; Li J; Karlsson R; Hall P; Czene K
    Breast Cancer Res; 2018 Apr; 20(1):30. PubMed ID: 29665850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.
    Huo Z; Giger ML; Olopade OI; Wolverton DE; Weber BL; Metz CE; Zhong W; Cummings SA
    Radiology; 2002 Nov; 225(2):519-26. PubMed ID: 12409590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term exposure to insulin and volumetric mammographic density: observational and genetic associations in the Karma study.
    Borgquist S; Rosendahl AH; Czene K; Bhoo-Pathy N; Dorkhan M; Hall P; Brand JS
    Breast Cancer Res; 2018 Aug; 20(1):93. PubMed ID: 30092829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between mammographic density and volumetric fibroglandular tissue estimated on breast MR images.
    Wei J; Chan HP; Helvie MA; Roubidoux MA; Sahiner B; Hadjiiski LM; Zhou C; Paquerault S; Chenevert T; Goodsitt MM
    Med Phys; 2004 Apr; 31(4):933-42. PubMed ID: 15125012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal and perinatal correlates of adult mammographic breast density.
    Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of area- and volumetric-mammographic density and breast cancer risk in women of Asian descent: a case control study.
    Mariapun S; Ho WK; Eriksson M; Mohd Taib NA; Yip CH; Rahmat K; Hall P; Teo SH
    Breast Cancer Res; 2024 May; 26(1):79. PubMed ID: 38750574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eligibility for magnetic resonance imaging screening in the United Kingdom: effect of strict selection criteria and anonymous DNA testing on breast cancer incidence in the MARIBS Study.
    Evans DG; Lennard F; Pointon LJ; Ramus SJ; Gayther SA; Sodha N; Kwan-Lim GE; Leach MO; Warren R; Thompson D; Easton DF; Eeles R;
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2123-31. PubMed ID: 19567506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
    Warner E; Plewes DB; Hill KA; Causer PA; Zubovits JT; Jong RA; Cutrara MR; DeBoer G; Yaffe MJ; Messner SJ; Meschino WS; Piron CA; Narod SA
    JAMA; 2004 Sep; 292(11):1317-25. PubMed ID: 15367553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.
    Gierach GL; Loud JT; Chow CK; Prindiville SA; Eng-Wong J; Soballe PW; Giambartolomei C; Mai PL; Galbo CE; Nichols K; Calzone KA; Vachon C; Gail MH; Greene MH
    Breast Cancer Res Treat; 2010 Aug; 123(1):245-55. PubMed ID: 20130984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer.
    Griebsch I; Brown J; Boggis C; Dixon A; Dixon M; Easton D; Eeles R; Evans DG; Gilbert FJ; Hawnaur J; Kessar P; Lakhani SR; Moss SM; Nerurkar A; Padhani AR; Pointon LJ; Potterton J; Thompson D; Turnbull LW; Walker LG; Warren R; Leach MO;
    Br J Cancer; 2006 Oct; 95(7):801-10. PubMed ID: 17016484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
    Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
    Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genetic variants associated with breast cancer and mammographic density measures that predict disease.
    Odefrey F; Stone J; Gurrin LC; Byrnes GB; Apicella C; Dite GS; Cawson JN; Giles GG; Treloar SA; English DR; Hopper JL; Southey MC;
    Cancer Res; 2010 Feb; 70(4):1449-58. PubMed ID: 20145138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.